Trypanosomiasis, African: Clinical Trials

5 trials for Trypanosomiasis, African, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Terminated 1

Follow Trypanosomiasis, African: new trials by email Literature Review of Trypanosomiasis, African trials Research Report on Trypanosomiasis, African

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan
Acoziborole, Midazolam, Dextromethorphan - Trypanosomiasis, African
Phase 1CompletedDrugs for Neglected Diseases202023-02-092023-07-17
ADME Study of Acoziborole in Healthy Subjects
[14C]-acoziborole capsule, 240 mg containing NMT 9.25 kBq (250 nCi) 14C - Trypanosomiases, African
Phase 1CompletedDrugs for Neglected Diseases62020-02-052021-04-27
Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation
Fexinidazole - Trypanosomiasis, African
Phase 1CompletedDrugs for Neglected Diseases302015-03-012015-10-08
Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
SCYX-7158, Placebo - Trypanosomiasis, Trypanosomiasis, African
Phase 1CompletedDrugs for Neglected Diseases1362012-02-012015-09-18
Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food
Tablets Fexinidazole, Placebo - Trypanosomiasis, African
Phase 1TerminatedDrugs for Neglected Diseases302011-09-012017-03-31

Narrower conditions

Neglected Diseases (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Trypanosomiasis (1)

Broader conditions

Euglenozoa Infections (5)  ·  Infections (5)  ·  Vector Borne Diseases (5)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (4)  ·  Trypanosomiasis (4)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

fexinidazole (2)  ·  Dextromethorphan (1)  ·  Midazolam (1)  ·  SCYX 7158 (1)

Sponsors

Drugs for Neglected Diseases (5)

Countries

France (3)  ·  Malaysia (1)  ·  United Kingdom (1)

Top investigators

Antoine Tarral, MD (2)  ·  Lionel Hovsepian, MD (1)  ·  Sharan Sidhu, MBChB (1)  ·  Sharon Ng Shi Min (1)

Results publications

PMID 36763327